Annual Net Income
-$152.99 M
-$48.31 M-46.15%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual net profit is -$152.99 million, with the most recent change of -$48.31 million (-46.15%) on December 31, 2023.
- During the last 3 years, KROS annual net income has fallen by -$107.63 million (-237.28%).
- KROS annual net income is now -11360.07% below its all-time high of -$1.33 million, reached on December 31, 2018.
Performance
KROS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$52.96 M
-$7.70 M-17.01%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly net profit is -$52.96 million, with the most recent change of -$7.70 million (-17.01%) on September 30, 2024.
- Over the past year, KROS quarterly net income has dropped by -$12.71 million (-31.59%).
- KROS quarterly net income is now -1824.97% below its all-time high of -$2.75 million, reached on December 31, 2019.
Performance
KROS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$181.57 M
-$13.52 M-8.04%
September 30, 2024
Summary
- As of February 8, 2025, KROS TTM net profit is -$181.57 million, with the most recent change of -$13.52 million (-8.04%) on September 30, 2024.
- Over the past year, KROS TTM net income has dropped by -$28.58 million (-18.68%).
- KROS TTM net income is now -5604.37% below its all-time high of -$3.18 million, reached on March 31, 2019.
Performance
KROS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
KROS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.1% | -31.6% | -18.7% |
| 3 y3 years | -237.3% | -160.9% | -190.6% |
| 5 y5 years | -10000.0% | -1392.1% | -1371.9% |
KROS Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -160.4% | at low | -663.0% | at low | -209.1% | at low |
| 5 y | 5-year | -1140.2% | at low | -1825.0% | at low | -1371.9% | at low |
| alltime | all time | <-9999.0% | at low | -1825.0% | at low | -5604.4% | at low |
Keros Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$52.96 M(+17.0%) | -$181.57 M(+8.0%) |
| Jun 2024 | - | -$45.26 M(+5.0%) | -$168.05 M(+4.8%) |
| Mar 2024 | - | -$43.11 M(+7.1%) | -$160.30 M(+4.8%) |
| Dec 2023 | -$152.99 M(+46.2%) | -$40.24 M(+2.0%) | -$152.99 M(+7.4%) |
| Sep 2023 | - | -$39.44 M(+5.2%) | -$142.47 M(+12.6%) |
| Jun 2023 | - | -$37.51 M(+4.8%) | -$126.54 M(+8.8%) |
| Mar 2023 | - | -$35.80 M(+20.5%) | -$116.30 M(+11.1%) |
| Dec 2022 | -$104.68 M(+78.2%) | -$29.72 M(+26.4%) | -$104.68 M(+27.8%) |
| Sep 2022 | - | -$23.51 M(-13.8%) | -$81.90 M(+4.1%) |
| Jun 2022 | - | -$27.27 M(+12.7%) | -$78.69 M(+17.4%) |
| Mar 2022 | - | -$24.19 M(+248.5%) | -$67.05 M(+14.1%) |
| Dec 2021 | -$58.74 M | -$6.94 M(-65.8%) | -$58.74 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$20.30 M(+29.9%) | -$62.48 M(+15.2%) |
| Jun 2021 | - | -$15.62 M(-1.7%) | -$54.22 M(+9.9%) |
| Mar 2021 | - | -$15.88 M(+48.8%) | -$49.35 M(+8.8%) |
| Dec 2020 | -$45.36 M(+267.7%) | -$10.68 M(-11.3%) | -$45.36 M(+21.2%) |
| Sep 2020 | - | -$12.04 M(+11.9%) | -$37.44 M(+29.3%) |
| Jun 2020 | - | -$10.76 M(-9.5%) | -$28.95 M(+37.6%) |
| Mar 2020 | - | -$11.89 M(+332.3%) | -$21.05 M(+70.6%) |
| Dec 2019 | -$12.34 M(+824.0%) | -$2.75 M(-22.5%) | -$12.34 M(+28.7%) |
| Sep 2019 | - | -$3.55 M(+24.4%) | -$9.59 M(+58.8%) |
| Jun 2019 | - | -$2.85 M(-10.4%) | -$6.04 M(+89.6%) |
| Mar 2019 | - | -$3.18 M | -$3.18 M |
| Dec 2018 | -$1.33 M | - | - |
FAQ
- What is Keros Therapeutics annual net profit?
- What is the all time high annual net income for Keros Therapeutics?
- What is Keros Therapeutics annual net income year-on-year change?
- What is Keros Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Keros Therapeutics?
- What is Keros Therapeutics quarterly net income year-on-year change?
- What is Keros Therapeutics TTM net profit?
- What is the all time high TTM net income for Keros Therapeutics?
- What is Keros Therapeutics TTM net income year-on-year change?
What is Keros Therapeutics annual net profit?
The current annual net income of KROS is -$152.99 M
What is the all time high annual net income for Keros Therapeutics?
Keros Therapeutics all-time high annual net profit is -$1.33 M
What is Keros Therapeutics annual net income year-on-year change?
Over the past year, KROS annual net profit has changed by -$48.31 M (-46.15%)
What is Keros Therapeutics quarterly net profit?
The current quarterly net income of KROS is -$52.96 M
What is the all time high quarterly net income for Keros Therapeutics?
Keros Therapeutics all-time high quarterly net profit is -$2.75 M
What is Keros Therapeutics quarterly net income year-on-year change?
Over the past year, KROS quarterly net profit has changed by -$12.71 M (-31.59%)
What is Keros Therapeutics TTM net profit?
The current TTM net income of KROS is -$181.57 M
What is the all time high TTM net income for Keros Therapeutics?
Keros Therapeutics all-time high TTM net profit is -$3.18 M
What is Keros Therapeutics TTM net income year-on-year change?
Over the past year, KROS TTM net profit has changed by -$28.58 M (-18.68%)